Bintrafusp alfa plus paclitaxel for advanced gastric cancer as a second-line treatment: An open label, single-arm, phase Ib/II study.

被引：0
|
作者：
Lee, Choong-kun
Jung, Minkyu
Park, Sejung
Kwon, Woo Sun
Kim, Kyoo Hyun
Hong, Moonki
Kim, Hyunwook
Kim, Hyo Song
Chung, Hyun Cheol Cheol
Rha, Sun Young
机构：
[1] Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol,Yonsei Canc Ctr, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Songdang Inst Canc Res, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
374
引用
收藏
页码：374 / 374
页数：1
相关论文
共 50 条
  • [41] A phase II single-arm pilot study of second-line icotinib treatment in advanced esophageal cancer with EGFR over-expression or amplification.
    Huang, Jing
    Fan, Qingxia
    Lu, Ping
    Ying, Jianming
    Ma, Changwu
    Liu, Wei
    Liu, Junfeng
    Liu, Ying
    Tan, Fenlai
    Sun, Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] A phase II single-arm study of pazopanib and paclitaxel as first-line treatment for patients with advanced melanoma
    Fruehauf, John P.
    Alger, Beverly
    Jakowatz, James G.
    Hsiang, David
    Sender, Leonard S.
    Bettis, Claudette
    Casey, Cameron
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [43] HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial
    Song, Yan
    Li, Ning
    Li, Qun
    Liang, Xinjun
    Zhang, Shu
    Fan, Qingxia
    Yin, Xianli
    Zhuang, Zhixiang
    Liu, Yunpeng
    Zhang, Jingdong
    Kou, Xiaoge
    Zhong, Haijun
    Wang, Xiaofei
    Dou, Yiwei
    Huang, Jing
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [44] A phase II, open labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine corpus cancer: KCOGG1303 study.
    Hori, Kensuke
    Nishio, Shin
    Ushijima, Kimio
    Kasamatsu, Yuka
    Kondo, Eiji
    Takehara, Kazuhiro
    Kakubari, Reisa
    Ito, Kimihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric cancer (CCOG0302 study)
    Kodera, Yasuhiro
    Ito, Seiji
    Mochizuki, Yoshinari
    Fujitake, Shinichi
    Koshikawa, Katsumi
    Kanyama, Yasuaki
    Matsui, Takanori
    Kojima, Hiroshi
    Takase, Tsunenobu
    Ohashi, Norifumi
    Fujiwara, Michitaka
    Sakamoto, Junichi
    Nakao, Akimasa
    ANTICANCER RESEARCH, 2007, 27 (4C) : 2667 - 2671
  • [46] An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma
    Agulnik, Mark
    Schulte, Brian
    Robinson, Steven
    Hirbe, Angela C.
    Kozak, Kevin
    Chawla, Sant P.
    Attia, Steven
    Rademaker, Alfred
    Zhang, Hui
    Abbinanti, Susan
    Cehic, Rasima
    Monga, Varun
    Milhem, Mohammed
    Okuno, Scott
    Van Tine, Brian A.
    EUROPEAN JOURNAL OF CANCER, 2021, 154 : 201 - 208
  • [47] Trastuzumab plus docetaxel and capecitabine as a first-line treatment for HER2-positive advanced gastric or gastroesophageal junction cancer: a phase II, multicenter, open-label, single-arm study
    Wang, Feng
    Liu, Tian-Shu
    Yuan, Xiang-Lin
    Luo, Hui-Yan
    Gu, Kang-Sheng
    Yuan, Ying
    Deng, Yan-Hong
    Xu, Jian-Ming
    Bai, Yu-Xian
    Wang, Ying
    Liao, Wang-Jun
    Zhang, He-Long
    Bi, Feng
    Wang, Bang-Mao
    Zhuang, Zhi-Xiang
    Jiang, Teng-Jia
    Xu, Rui-Hua
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (09): : 3037 - +
  • [48] Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study
    Lee, Choong-kun
    Lee, Jii Bum
    Park, Se Jung
    Che, Jingmin
    Kwon, Woo Sun
    Kim, Hyo Song
    Jung, Minkyu
    Lee, Seulkee
    Park, Sook Ryun
    Koo, Dong-Hoe
    Lee, Hyun Woo
    Bae, Woo Kyun
    Jeung, Hei-Cheul
    Hwang, In Gyu
    Kim, Hyunki
    Nam, Chung Mo
    Chung, Hyun Cheol
    Rha, Sun Young
    GASTRIC CANCER, 2024, 27 (01) : 118 - 130
  • [49] Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study
    Choong-kun Lee
    Jii Bum Lee
    Se Jung Park
    Jingmin Che
    Woo Sun Kwon
    Hyo Song Kim
    Minkyu Jung
    Seulkee Lee
    Sook Ryun Park
    Dong-Hoe Koo
    Hyun Woo Lee
    Woo Kyun Bae
    Hei-Cheul Jeung
    In Gyu Hwang
    Hyunki Kim
    Chung Mo Nam
    Hyun Cheol Chung
    Sun Young Rha
    Gastric Cancer, 2024, 27 : 118 - 130
  • [50] Randomized Phase II trial of paclitaxel plus valproic acid vs paclitaxel alone as second-line therapy for patients with advanced gastric cancer
    Fushida, Sachio
    Kaji, Masahide
    Oyama, Katsunobu
    Hirono, Yasuo
    Nezuka, Hideaki
    Takeda, Toshiya
    Tsukada, Tomoya
    Fujimoto, Daisuke
    Ohyama, Shigekazu
    Fujimura, Takashi
    Ohta, Tetsuo
    ONCOTARGETS AND THERAPY, 2015, 8 : 939 - 941
12345